Amanda Maxwell

Amanda has over 30 years of experience in reporting and providing analysis on developments in the field of medical technology regulatory affairs, with a particular focus on the current and future EU regulations for medical devices, IVDs, and device/drug combination products.

Amanda closely monitors the implementation of the Medical Device and IVD Regulations and the challenges that the sector is encountering is being in compliance in time. In so doing, she keeps in constant communication with a broad base of expert contacts around Europe. Moreover, as the UK heads for Brexit, she monitors the likely impact of political developments on the MedTech sector.

Amanda also has experience in providing MedTech regulatory strategy consultancy services and is a frequently invited speaker and chair at EU meetings on Medtech regulations and drug/device combination regulatory issues.